Literature DB >> 28325194

Multimodality Treatment of Gastric Lymphoma.

Naruhiko Ikoma1, Brian D Badgwell1, Paul F Mansfield2.   

Abstract

Gastric lymphoma is rare, accounting for 3% of gastric neoplasms and 10% of lymphomas. Treatment should be stratified based on histologic type, stage, Helicobacter pylori infection, and t(11;18) translocation status. Surgery is no longer a mainstay for treatment and should be reserved for rare situations such as perforation, fistula formation, and severe bleeding. Multimodal treatment, including H pylori eradication, radiation therapy, chemotherapy, and immunotherapy, should be provided as appropriate and can result in excellent outcomes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Helicobacter pylori infection; Primary gastric lymphoma; Radiation therapy; Surgery

Mesh:

Year:  2017        PMID: 28325194     DOI: 10.1016/j.suc.2016.11.012

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  7 in total

1.  Post-chemotherapy Gastric Obstruction in Diffuse Large B-Cell Lymphoma: Endoscopic Dilation Can Fix It!

Authors:  Khalaf Ben Abdallah; Asma Ben Mohamed; Manel Yacoubi; Amal Khsiba; Amel Dougaz; Emna Chelbi; Lamine Hamzaoui
Journal:  Case Rep Gastroenterol       Date:  2022-05-17

2.  A dynamic predictive nomogram of long-term survival in primary gastric lymphoma: a retrospective study.

Authors:  Jinru Yang; Tao Liu; Ying Zhu; Fangyuan Zhang; Menglan Zhai; Dejun Zhang; Lei Zhao; Min Jin; Zhenyu Lin; Tao Zhang; Liling Zhang; Dandan Yu
Journal:  BMC Gastroenterol       Date:  2022-07-16       Impact factor: 2.847

3.  Switching Fractioned R-CHOP Cycles to Standard R-CHOP Cycles Guided by Endoscopic Ultrasonography in Treating Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.

Authors:  Yizhen Liu; Yumei Liu; Ping Zhao; Qunling Zhang; Xiaojian Liu; Fangfang Lv; Xiaonan Hong; Junning Cao; Kai Xue
Journal:  Cancer Manag Res       Date:  2020-06-25       Impact factor: 3.989

4.  Complications and outcomes in diffuse large B-cell lymphoma with gastric lesions treated with R-CHOP.

Authors:  Tomohiro Kadota; Sachiko Seo; Hiroe Fuse; Genichiro Ishii; Kuniaki Itoh; Tomonori Yano; Kazuhiro Kaneko; Kunihiro Tsukasaki
Journal:  Cancer Med       Date:  2019-02-07       Impact factor: 4.452

5.  Development and External Validation of a Nomogram to Predict Cancer-Specific Survival in Patients with Primary Intestinal Non-Hodgkin Lymphomas.

Authors:  Cuifen Zhang; Zeyu Liu; Jiahao Tao; Lizhu Lin; Linzhu Zhai
Journal:  Cancer Manag Res       Date:  2021-12-20       Impact factor: 3.989

6.  The impact of surgery on long-term survival of patients with primary intestinal non-Hodgkin lymphomas based on SEER database.

Authors:  Cuifen Zhang; Xiaohong Zhang; Zeyu Liu; Jiahao Tao; Lizhu Lin; Linzhu Zhai
Journal:  Sci Rep       Date:  2021-11-29       Impact factor: 4.379

7.  Helicobacter pylori infection disturbs the tumor immune microenvironment and is associated with a discrepant prognosis in gastric de novo diffuse large B-cell lymphoma.

Authors:  Yuwei Deng; Wenjia Su; Junwen Zhu; Hongfei Ji; Xiaoping Zhou; Jingshu Geng; Jiayu Zhu; Qingyuan Zhang
Journal:  J Immunother Cancer       Date:  2021-10       Impact factor: 13.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.